There are numerous alternative therapies that can complement the treatment of chronic conditions. Craniosacral therapy, also ...
BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.
Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).